Keeping appraised of the latest developments in HIV/AIDS treatment is the best way to make sure your particular therapy regime is optimum. Each of the following sites will give you news about the latest protocols, and other important news for people living with HIV.
- CDC National Prevention Information Network Prevention News Update
(Formerly the CDC Daily AIDS Summary, and still referred to as such by many organizations.)
This daily update contains abstracts of peer-reviewed medical journal articles concerning HIV/AIDS, as well as clippings of note from worldwide media sources about AIDS and related conditions. Although much of the information is not of immediate use to an individual looking for treatment guidance, this resource will be the very first place where information about new protocols, study results, and success statistics will be widely reported. At the bottom of the page, you'll find information about how you may receive the daily update via email.
- Office of Special Health
Issues HIV/AIDS What's New
This page tracks new additions to the FDA's OSHI-HIV/AIDS page. Not all of the information here is of particular use to people living with HIV, but the FDA does list new drug approvals and information about possible drug interactions or contraindications on this site.
- AIDS Treatment Information
Service What's New page.
The AIDS Treatment Information Service is a Public Health Service project cosponsored by several different federal departments and agencies. This page contains what its editors feel are the most significant news releases concerning HIV/AIDS that are issued by the agencies involved.
- Critical Path AIDS Project's Late Breaking
Bulletins page. Critical Path is a nonprofit AIDS Service
Organization. This bulletin page is updated daily.
- San Francisco AIDS Foundation's Bulletin of Experimental
Treatments of AIDS (BETA)
BETA publishes a quarterly newsletter and reproduces it in its entirety on this site. Topics include new information about available drugs and new protocols, updates on research into new drugs, information on promising alternative therapies, and updates from AIDS-related conferences.
